SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-233317
Filing Date
2012-05-15
Accepted
2012-05-15 10:53:43
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d334328d10q.htm 10-Q 447572
2 ASSET PURCHASE AGREEMENT d334328dex21.htm EX-2.1 320827
3 ASSET PURCHASE AGREEMENT d334328dex22.htm EX-2.2 216731
4 CONSENT AND WAIVER d334328dex102.htm EX-10.2 15308
5 SECTION 302 CEO CERTIFICATION d334328dex311.htm EX-31.1 9289
6 SECTION 302 CFO CERTIFICATION d334328dex312.htm EX-31.2 9428
7 SECTION 906 CEO CERTIFICATION d334328dex321.htm EX-32.1 4608
8 SECTION 906 CFO CERTIFICATION d334328dex322.htm EX-32.2 4798
  Complete submission text file 0001193125-12-233317.txt   2402671

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT crtx-20120331.xml EX-101.INS 211897
10 XBRL TAXONOMY EXTENSION SCHEMA crtx-20120331.xsd EX-101.SCH 8383
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crtx-20120331_cal.xml EX-101.CAL 29635
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE crtx-20120331_lab.xml EX-101.LAB 104265
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crtx-20120331_pre.xml EX-101.PRE 65126
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 12841912
SIC: 2834 Pharmaceutical Preparations